FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Martin Bornhäuser

Research Profile

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Phenomena

Recurrence

Anatomy

Physiology

Cell Differentiation

Co-author Network

Publications

TOP 3
Claudia Ortlepp; Martin Ryser; Christine Steudel; Martin Bornhäuser; Sebastian Brenner; Benedikt Brors; Gerhard Ehninger; Caroline Heiderich; Wolf-Karsten Hofmann; Angela Jacobi; Sina Koch; Christian Thiede
Autotaxin is expressed in FLT3-ITD positive acute myeloid leukemia and hematopoietic stem cells and promotes cell migration and proliferation.
Stefanie Koristka; Irene Michalk; Marc Schmitz; Slava Stamova; Kristin Wiefel; Claudia C Bippes; Martin Bornhäuser; Marc Cartellieri; Gerhard Ehninger; Anja Feldmann; Claudia Arndt; Michael Bachmann
Retargeting of regulatory T cells to surface-inducible autoantigen La/SS-B.
Brigitte Mohr; Andreas Neubauer; Uwe Platzbecker; Wolf Rösler; Kerstin Schäfer-Eckart; Markus Schaich; Johannes Schetelig; Norbert Schmitz; Ulrich Schuler; Friedrich Stölzel; Martin Bornhäuser; Gerhard Ehninger; Norbert Frickhofen; Mathias Hänel; Hartmut Link; Jan M Middeke
Impact of allogeneic haematopoietic stem cell transplantation in patients with abnl(17p) acute myeloid leukaemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Martin Bornhäuser (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Claudia Ortlepp; Martin Ryser; Christine Steudel; Martin Bornhäuser; Sebastian Brenner; Benedikt Brors; Gerhard Ehninger; Caroline Heiderich; Wolf-Karsten Hofmann; Angela Jacobi; Sina Koch; Christian Thiede
Autotaxin is expressed in FLT3-ITD positive acute myeloid leukemia and hematopoietic stem cells and promotes cell migration and proliferation.
Experimental hematology 2013;41(5):444-461.e4.
2013: Stefanie Koristka; Irene Michalk; Marc Schmitz; Slava Stamova; Kristin Wiefel; Claudia C Bippes; Martin Bornhäuser; Marc Cartellieri; Gerhard Ehninger; Anja Feldmann; Claudia Arndt; Michael Bachmann
Retargeting of regulatory T cells to surface-inducible autoantigen La/SS-B.
Journal of autoimmunity 2013;42():105-16.
2013: Brigitte Mohr; Andreas Neubauer; Uwe Platzbecker; Wolf Rösler; Kerstin Schäfer-Eckart; Markus Schaich; Johannes Schetelig; Norbert Schmitz; Ulrich Schuler; Friedrich Stölzel; Martin Bornhäuser; Gerhard Ehninger; Norbert Frickhofen; Mathias Hänel; Hartmut Link; Jan M Middeke
Impact of allogeneic haematopoietic stem cell transplantation in patients with abnl(17p) acute myeloid leukaemia.
British journal of haematology 2013;161(2):237-44.
2013: C Arndt; Martin Bornhäuser; Marc Cartellieri; G Ehninger; A Feldmann; S Koristka; I Michalk; M Schmitz; S Stamova; M von Bonin; M Bachmann
Redirection of T cells with a first fully humanized bispecific CD33-CD3 antibody efficiently eliminates AML blasts without harming hematopoietic stem cells.
Leukemia 2013;27(4):964-7.
2013: Sabine Stopp; Martin Bornhäuser; Sebastian Brenner; Matthias Kuhn; Fernando Ugarte; Manja Wobus; Sebastian Thieme
Expression of the melanoma cell adhesion molecule in human mesenchymal stromal cells regulates proliferation, differentiation, and maintenance of hematopoietic stem and progenitor cells.
Haematologica 2013;98(4):505-13.
2013: Felix Bahr; Martin Bornhäuser; Gerhard Ehninger; Jan Moritz Middeke; Uwe Platzbecker; Christoph Röllig; Johannes Schetelig; Marc Schmitz; Nona Shayegi; Rebekka Wehner; Martin Wermke; Sebastian Tuve
Reconstitution of interleukin-17-producing T helper cells after allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(3):357-65.
2013: Rainer Ordemann; Uwe Platzbecker; I Platzek; J Stöhlmacher; J van den Hoff; C Zietz; B Beuthien-Baumann; Martin Bornhäuser; Frank Kroschinsky; J M Middeke; Gerhard Ehninger
Use of targeted therapy for refractory ALK-positive anaplastic large cell lymphoma as a bridging strategy prior to allogeneic transplantation.
Annals of hematology 2013;92(1):125-7.
2012: Martin Wermke; Martin Bornhäuser; Gerhard Ehninger; Michael Laniado; Sabine M Mair; Jan Moritz Middeke; Verena Plodeck; Johannes Schetelig; Anne Schmidt; Claudia Schönefeldt; Katja Sockel; Igor Theurl; M von Bonin; Günter Weiss; Uwe Platzbecker
MRI-based liver iron content predicts for nonrelapse mortality in MDS and AML patients undergoing allogeneic stem cell transplantation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(23):6460-8.
2012: Kristina Hölig; Michael Kramer; Frank Kroschinsky; Kirsten Poppe-Thiede; Kristin Zimmer; Matthias Blechschmidt; Martin Bornhäuser; Gerhard Ehninger
Peripheral blood stem cell collection in allogeneic donors: impact of venous access.
Transfusion 2012;52(12):2600-5.
2012: Frederick Fasslrinner; Lorenz C Hofbauer; Katrin Müller; Martina Rauner; Marc Schmitz; Sabine Stopp; Rebekka Wehner; Manja Wobus; Regina Duryagina; Martin Bornhäuser
Differential effects of mixed lymphocyte reaction supernatant on human mesenchymal stromal cells.
Experimental hematology 2012;40(11):934-44.
2012: Jürgen Finke; Olga Grishina; Dominik A Heim; Ernst Holler; Karin Kolbe; Vladimir Koza; Werner Linkesch; Johan A Maertens; Jiri Mayer; Hellmut D Ottinger; Claudia Schmoor; Rainer Schwerdtfeger; Gérard Socié; Matthias Stelljes; Liisa Volin; Axel R Zander; Hartmut Bertz; Wolfgang A Bethge; Martin Bornhäuser; Hermann Einsele
Prognostic factors affecting outcome after allogeneic transplantation for hematological malignancies from unrelated donors: results from a randomized trial.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(11):1716-26.
2012: Martin Bornhäuser; Stefanie Buchholz; Andreas Burchert; Peter Dreger; Gerhard Ehninger; Herrmann Einsele; Ute Hegenbart; Wolfgang Hiddemann; Ernst Holler; Michael G Kiehl; Joachim Kienast; Nicolaus Kröger; Andreas Neubauer; Kerstin Schäfer-Eckart; Johannes Schetelig; Christoph Schmid; Rainer Schwerdtfeger; Michael Stadler; Herrad Baurmann; Dietrich W Beelen; Wolfgang E Berdel; Rudolf Trenschel; Matthias Stelljes
Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial.
The lancet oncology 2012;13(10):1035-44.
2012: Jan J Cornelissen; Alois Gratwohl; Gunnar Juliusson; Bob Löwenberg; Mohamad Mohty; Dietger Niederwieser; Zdenek Råcil; Jacob M Rowe; Nigel Russell; Richard F Schlenk; Jorge Sierra; Gerard Socie; Martin Bornhäuser; Gert J Ossenkoppele
The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach.
Nature reviews. Clinical oncology 2012;9(10):579-90.
2012: Evgeny Klyuchnikov; Guido Kobbe; Christian Könecke; Arnon Nagler; Avichai Shimoni; Christine Wolschke; Axel R Zander; Ulrike Bacher; Martin Bornhäuser; Ernst Holler; Nicolaus Kröger
Donor lymphocyte infusions and second transplantation as salvage treatment for relapsed myelofibrosis after reduced-intensity allografting.
British journal of haematology 2012;159(2):172-81.
2012: Manja Wobus; Martina Rauner; Marc Schmitz; Rebekka Wehner; Gwendolin Benath; Martin Bornhäuser; Gerhard Ehninger; Ruben A Ferrer; Lorenz C Hofbauer; Uwe Platzbecker
Impact of lenalidomide on the functional properties of human mesenchymal stromal cells.
Experimental hematology 2012;40(10):867-76.
2012: Jan M Middeke; Brigitte Mohr; Johannes Schetelig; Brigitte Schlegelberger; Rainer Schwerdtfeger; Michael Stadler; Herrad Baurmann; Dietrich Beelen; Frauke Bellos; Martin Bornhäuser; Stefanie Buchholz; Gesine Bug; Gerhard Ehninger; Gudrun Göhring; Ute Hegenbart; Hans Martin
Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and -5/5q-.
Blood 2012;120(12):2521-8.
2012: Anja Feldmann; Stefanie Koristka; Franziska Krone; Dirk Lindemann; Irene Michalk; Marc Schmitz; Slava Stamova; Achim Temme; Katrin Töpfer; Claudia Arndt; Martin Bornhäuser; Marc Cartellieri; Gerhard Ehninger; Michael Bachmann
Novel humanized and highly efficient bispecific antibodies mediate killing of prostate stem cell antigen-expressing tumor cells by CD8+ and CD4+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 2012;189(6):3249-59.
2012: Uwe Platzbecker; Kerstin Schaefer-Eckart; Johannes Schetelig; Bart L Scott; Rudolf Trenschel; Lionel Adès; Dietrich Beelen; Martin Bornhäuser; H Joachim Deeg; Gerhard Ehninger; Pierre Fenaux; Jürgen Finke; Ulrich Germing; Raphael Itzykson; Guido Kobbe
Allogeneic hematopoietic cell transplantation in patients age 60-70 years with de novo high-risk myelodysplastic syndrome or secondary acute myelogenous leukemia: comparison with patients lacking donors who received azacitidine.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(9):1415-21.
2012: Konrad Mager; Jan Moritz Middeke; U Oelschlägel; Uwe Platzbecker; Jörgen Radke; Christoph Röllig; Johannes Schetelig; Marc Schmitz; Nona Shayegi; Christian Thiede; Felix Bahr; Martin Bornhäuser; Gerhard Ehninger; Rebekka Wehner; Martin Wermke; Sebastian Tuve
Reconstitution of 6-sulfo LacNAc dendritic cells after allogeneic stem-cell transplantation.
Transplantation 2012;93(12):1270-5.
2012: Stefani Parmentier; Gabi Rall; Markus Schaich; Johannes Schetelig; Ulrich Schuler; Martin Bornhäuser; Gerhard Ehninger; Robin Ireland; Michael Kramer; Kerstin Lorenz; Rainer Ordemann; Frank Kroschinsky
Assessment of dysplastic hematopoiesis: lessons from healthy bone marrow donors.
Haematologica 2012;97(5):723-30.
2012: Friedrich Stölzel; Christian Thiede; Christian Zietz; Gustavo B Baretton; Gerhard Ehninger; Monika Füssel; Karl Hackmann; Arndt Hartmann; Thomas Illmer; Friederike Kuithan; Brigitte Mohr; U Oelschlägel; Uwe Platzbecker; Christoph Röllig; Markus Schaich; Johannes Schetelig; Evelin Schrock; Barbara Seliger; Martin Bornhäuser
Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation.
Transplantation 2012;93(7):744-9.
2012: Slava Stamova; Malte von Bonin; Rebekka Wehner; Falko Apel; Claudia Arndt; Holger Bartsch; Martin Bornhäuser; Marc Cartellieri; Gerhard Ehninger; Anja Feldmann; Stefanie Koristka; Marc Schmitz; Michael Bachmann
Generation of single-chain bispecific green fluorescent protein fusion antibodies for imaging of antibody-induced T cell synapses.
Analytical biochemistry 2012;423(2):261-8.
2012: Uwe Platzbecker; Martin Bornhäuser
SOS for veno-occlusive disease: defibrotide prophylaxis.
Lancet 2012;379(9823):1277-8.
2012: Haefaa Alchalby; Francis Ayuk; Ulrike Bacher; Wolfgang Bethge; Martin Bornhäuser; Guntram Büsche; Ernst Holler; Guido Kobbe; Hans Michael Kvasnicka; Rainer Schwerdtfeger; Dinah-Rohina Yunus; Tatjana Zabelina; Axel R Zander; Nicolaus Kröger
Risk models predicting survival after reduced-intensity transplantation for myelofibrosis.
British journal of haematology 2012;157(1):75-85.
2012: M Wermke; S Schiemanck; Martin Bornhäuser; Gerhard Ehninger; G Höffken; Thomas Illmer
Respiratory failure in patients undergoing allogeneic hematopoietic SCT--a randomized trial on early non-invasive ventilation based on standard care hematology wards.
Bone marrow transplantation 2012;47(4):574-80.
2012: Martina Rauner; Georg Schett; Thorsten Schinke; Jochen Schulze; Nicola Stein; Maria Winzer; Jochen Zwerina; Joachim Albers; Martin Bornhäuser; Jörg H W Distler; Claudia Goettsch; Uwe Platzbecker; Lorenz C Hofbauer
WNT5A is induced by inflammatory mediators in bone marrow stromal cells and regulates cytokine and chemokine production.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2012;27(3):575-85.
2012: Duohui Jing; Martin Bornhäuser; Gerhard Ehninger; David M Poitz; Manja Wobus; Rainer Ordemann
Oxygen tension plays a critical role in the hematopoietic microenvironment in vitro.
Haematologica 2012;97(3):331-9.
2012: Uwe Platzbecker; J Radke; Christoph Röllig; Johannes Schetelig; F Seltmann; M Wermke; Martin Bornhäuser; Gerhard Ehninger; X Graehlert; Alexander Kiani; I-M Klut; H Knoth; Brigitte Mohr; Uta Oelschlaegel; Christian Thiede
Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial.
Leukemia 2012;26(3):381-9.
2012: Markus Pfirrmann; Christoph Röllig; Markus Schaich; Christian Thiede; Martin Bornhäuser; Gerhard Ehninger; Joerg Hasford; Michael Kramer
Prediction of post-remission survival in acute myeloid leukaemia: a post-hoc analysis of the AML96 trial.
The lancet oncology 2012;13(2):207-14.
2012: Stefanie Koristka; Karsten Kretschmer; Irene Michalk; Marc Schmitz; Slava Stamova; Achim Temme; Anke Theil; Katrin Töpfer; Martin Bornhäuser; Marc Cartellieri; Gerhard Ehninger; Anja Feldmann; Claudia Arndt; Michael Bachmann
Retargeting of human regulatory T cells by single-chain bispecific antibodies.
Journal of immunology (Baltimore, Md. : 1950) 2012;188(3):1551-8.
2012: Andreas D Hofmann; Udo Krause-Buchholz; Mandy Beyer; Martin Bornhäuser; Manja Wobus; Gerhard Rödel
OXPHOS supercomplexes as a hallmark of the mitochondrial phenotype of adipogenic differentiated human MSCs.
PloS one 2012;7(4):e35160.
2011: Slava Stamova; Malte von Bonin; Rebekka Wehner; Claudia Arndt; Holger Bartsch; Claudia C Bippes; Martin Bornhäuser; Marc Cartellieri; Gerhard Ehninger; Anja Feldmann; Stefanie Koristka; Marc Schmitz; Michael Bachmann
Unexpected recombinations in single chain bispecific anti-CD3-anti-CD33 antibodies can be avoided by a novel linker module.
Molecular immunology 2011;49(3):474-82.
2011: Nicole Birninger; Martin Bornhäuser; Gerhard Ehninger; Markus Schaich; Johannes Schetelig
The hematopoietic cell transplantation-specific comorbidity index fails to predict outcomes in high-risk AML patients undergoing allogeneic transplantation--investigation of potential limitations of the index.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(12):1822-32.
2011: Dmitriy Ovcharenko; David Poitz; Markus Schaich; Friedrich Stölzel; Christian Thiede; Martin Bornhäuser; David Brown; Timothy Davison; Gerhard Ehninger; Fernando Fierro; Kevin Kelnar; Carsten Müller-Tidow; Andreas Neubauer; Thomas Illmer
miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia.
Experimental hematology 2011;39(10):1030-1042.e7.
2011: Katja Sockel; Christian Thiede; Martin Wermke; Jörgen Radke; Markus Schaich; Martin Bornhäuser; Gerhard Ehninger; Alexander Kiani; Uwe Platzbecker
Minimal residual disease-directed preemptive treatment with azacitidine in patients with NPM1-mutant acute myeloid leukemia and molecular relapse.
Haematologica 2011;96(10):1568-70.
2011: Friedrich Stölzel; Klaus Zöphel; Martin Bornhäuser; Gerhard Ehninger; Brigitte Mohr; Tobias Paulus; Uwe Platzbecker; Jörgen Radke; Christoph Röllig; Markus Schaich
¹⁸F-FDG-PET/CT for detection of extramedullary acute myeloid leukemia.
Haematologica 2011;96(10):1552-6.
2011: Christian Hedrich; Martin Bornhäuser; Normi Bruck; Barbara Fiebig; Manfred Gahr; Gabriele Hahn; Meinolf Suttorp
Autologous stem cell transplantation in refractory paediatric Wegener's granulomatosis.
Clinical and experimental rheumatology 2011;29(5):897-8.
2011: Lidia Sobkow; Martin Bornhäuser; Juliane Drichel; Ina Kurth; Ljupco Prodanov; F Philipp Seib; Carsten Werner
Prolonged transendothelial migration of human haematopoietic stem and progenitor cells (HSPCs) towards hydrogel-released SDF1.
Annals of hematology 2011;90(8):865-71.
2011: Christoph Röllig; Kerstin Schäfer-Eckart; Markus Schaich; Ulrich Schuler; Friedrich Stölzel; Reingard Stuhlmann; Franziska Taube; Christian Thiede; Hans-Joachim Tischler; M von Bonin; Hannes Wandt; Walter Aulitzky; Heinrich Bodenstein; Martin Bornhäuser; Michael Kramer; Brigitte Mohr; Gerhard Ehninger
Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the proposed reporting system.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(20):2758-65.
2011: Markus Schaich; Johannes Schetelig; Norbert Schmitz; Silke Soucek; Reingard Stuhlmann; Christian Thiede; Joachim Tischler; Hannes Wandt; Anthony Ho; Martin Kaufmann; Alwin Krämer; Michael Kramer; Brigitte Mohr; Uta Oelschlaegel; Christoph Röllig; Kerstin Schäfer-Eckart; Walter Aulitzky; Heinrich Bodenstein; Martin Bornhäuser; Gerhard Ehninger
Cytarabine dose of 36 g/m² compared with 12 g/m² within first consolidation in acute myeloid leukemia: results of patients enrolled onto the prospective randomized AML96 study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(19):2696-702.
2011: Nicola Bauer; Martin Bornhäuser; Ana-Violeta Fonseca; Daniel Freund; Wieland B Huttner; Jana Karbanová; Doreen Strauss; Christoph Thiele; Michaela Wilsch-Bräuninger; Denis Corbeil
Haematopoietic stem cell differentiation promotes the release of prominin-1/CD133-containing membrane vesicles--a role of the endocytic-exocytic pathway.
EMBO molecular medicine 2011;3(7):398-409.
2011: Martin Bornhäuser; Gerhard Ehninger; Kristina Hölig; Hanka Jähnisch; Alexander Kiani; Doris Lehmann; Uta Oelschlaegel; Uwe Platzbecker; Jörgen Radke; E Peter Rieber; Johannes Schetelig; Christian Thiede; Sebastian Tuve; Rebekka Wehner; Martin Wermke; Jana Babatz; Michael P Bachmann; Marc Schmitz
Prophylactic transfer of BCR-ABL-, PR1-, and WT1-reactive donor T cells after T cell-depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemia.
Blood 2011;117(26):7174-84.
2011: Ina Kurth; Tilo Pompe; Martin Bornhäuser; Katja Franke; Carsten Werner
Extracellular matrix functionalized microcavities to control hematopoietic stem and progenitor cell fate.
Macromolecular bioscience 2011;11(6):739-47.
2011: Gérard Socié; Matthias Stelljes; Liisa Volin; Axel R Zander; Hartmut Bertz; Wolfgang A Bethge; Martin Bornhäuser; Matthias Egger; Hermann Einsele; Jürgen Finke; Olga Grishina; Dominik A Heim; Ernst Holler; Hans-Jochem Kolb; Karin Kolbe; Vladimir Koza; Werner Linkesch; Johan A Maertens; Jiri Mayer; Hellmut D Ottinger; Tapani Ruutu; Claudia Schmoor; Rainer Schwerdtfeger
Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius.
Blood 2011;117(23):6375-82.
2011: S Tuve; J Gayoso; C Scheid; J Radke; Alexander Kiani; D Serrano; Uwe Platzbecker; G Rodríguez-Macías; M Wermke; U Holtick; P Balsalobre; J M Middeke; N Shayegi; J M Chemnitz; A Krause; N Gruner; Monika Füssel; Johannes Schetelig; Christian Thiede; Gerhard Ehninger; M Hallek; J L Díez-Martín; Martin Bornhäuser
Haploidentical bone marrow transplantation with post-grafting cyclophosphamide: multicenter experience with an alternative salvage strategy.
Leukemia 2011;25(5):880-3.
2011: F Stölzel; M Pfirrmann; Walter Aulitzky; M Kaufmann; Heinrich Bodenstein; Martin Bornhäuser; Christoph Röllig; M Kramer; Brigitte Mohr; U Oelschlägel; Norbert Schmitz; Silke Soucek; Christian Thiede; Gerhard Ehninger; Markus Schaich
Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trial.
Leukemia 2011;25(3):420-8.
2011: Christian Niehage; Charlotte Steenblock; Theresia Pursche; Martin Bornhäuser; Denis Corbeil; Bernard Hoflack
The cell surface proteome of human mesenchymal stromal cells.
PloS one 2011;6(5):e20399.
2011: Christoph Röllig; Christian Schmidt; Martin Bornhäuser; Gerhard Ehninger; Marc Schmitz; Susanne Auffermann-Gretzinger
Induction of cellular immune responses in patients with stage-I multiple myeloma after vaccination with autologous idiotype-pulsed dendritic cells.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2011;34(1):100-6.
2010: Martin Wermke; Stefanie Maiwald; Renate Schmelz; Christian Thiede; Johannes Schetelig; Gerhard Ehninger; Martin Bornhäuser; Ralf Wassmuth
Genetic variations of interleukin-23R (1143A>G) and BPI (A645G), but not of NOD2, are associated with acute graft-versus-host disease after allogeneic transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(12):1718-27.
2010: Haefaa Alchalby; A Badbaran; Tatjana Zabelina; Guido Kobbe; Joachim Hahn; Daniel Wolff; Martin Bornhäuser; Christian Thiede; Herrad Baurmann; Wolfgang Bethge; York Hildebrandt; Ulrike Bacher; Boris Fehse; Axel R Zander; Nicolaus Kröger
Impact of JAK2V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis.
Blood 2010;116(18):3572-81.
2010: Rebekka Wehner; P Schumacher; Martin Bornhäuser; Gerhard Ehninger; Knut Schäkel; Michael Bachmann; Marc Schmitz
Acute myeloid leukemia cells fail to activate native human dendritic cells: a potential mechanism of immune evasion.
Leukemia 2010;24(11):1965-7.
2010: D Jing; N Alakel; Martin Bornhäuser; Gerhard Ehninger; Rainer Ordemann
SDF-1/CXCR4 blockade to mobilize hematopoietic progenitor cells from the placenta.
Bone marrow transplantation 2010;45(11):1661-2.
2010: Ana-Violeta Fonseca; Daniel Freund; Martin Bornhäuser; Denis Corbeil
Polarization and migration of hematopoietic stem and progenitor cells rely on the RhoA/ROCK I pathway and an active reorganization of the microtubule network.
The Journal of biological chemistry 2010;285(41):31661-71.
2010: D Jing; Uta Oelschlaegel; Rainer Ordemann; Kristina Hölig; Gerhard Ehninger; H Reichmann; T Ziemssen; Martin Bornhäuser
CD49d blockade by natalizumab in patients with multiple sclerosis affects steady-state hematopoiesis and mobilizes progenitors with a distinct phenotype and function.
Bone marrow transplantation 2010;45(10):1489-96.
2010: Maik Stiehler; F Philipp Seib; Juliane Rauh; Anja Goedecke; Carsten Werner; Martin Bornhäuser; Klaus-Peter Günther; Peter Bernstein
Cancellous bone allograft seeded with human mesenchymal stromal cells: a potential good manufacturing practice-grade tool for the regeneration of bone defects.
Cytotherapy 2010;12(5):658-68.
2010: Christoph Röllig; Christian Thiede; Martin Gramatzki; Walter Aulitzky; Heinrich Bodenstein; Martin Bornhäuser; Uwe Platzbecker; Reingard Stuhlmann; Ulrich Schuler; Silke Soucek; Michael Kramer; Brigitte Mohr; Uta Oelschlaegel; Friedrich Stölzel; M von Bonin; Martin Wermke; Hannes Wandt; Gerhard Ehninger; Markus Schaich
A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial.
Blood 2010;116(6):971-8.
2010: Christian Koenecke; Bernd Hertenstein; J Schetelig; A van Biezen; Elke Dammann; Alois Gratwohl; Arnold Ganser; M Schleuning; Martin Bornhäuser; N Jacobsen; N Kröger; Dietger Niederwieser; T de Witte; T Ruutu
Solid organ transplantation after allogeneic hematopoietic stem cell transplantation: a retrospective, multicenter study of the EBMT.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2010;10(8):1897-906.
2010: Martin Bornhäuser; Martin Aringer; Christian Thiede
Mixed lymphohematopoietic chimerism and response in Wegener's granulomatosis.
The New England journal of medicine 2010;362(25):2431-2.
2010: F Philipp Seib; Babette Lanfer; Martin Bornhäuser; Carsten Werner
Biological activity of extracellular matrix-associated BMP-2.
Journal of tissue engineering and regenerative medicine 2010;4(4):324-7.
2010: Senming Zhao; Rebekka Wehner; Martin Bornhäuser; Ralf Wassmuth; Michael Bachmann; Marc Schmitz
Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders.
Stem cells and development 2010;19(5):607-14.
2010: Daniel Freund; Ana-Violeta Fonseca; Peggy Janich; Martin Bornhäuser; Denis Corbeil
Differential expression of biofunctional GM1 and GM3 gangliosides within the plastic-adherent multipotent mesenchymal stromal cell population.
Cytotherapy 2010;12(2):131-42.
2010: Angela Jacobi; Sebastian Thieme; Romy Lehmann; Fernando Ugarte; Harry L Malech; Sina Koch; Christian Thiede; Katrin Müller; Martin Bornhäuser; Martin Ryser; Sebastian Brenner
Impact of CXCR4 inhibition on FLT3-ITD-positive human AML blasts.
Experimental hematology 2010;38(3):180-90.
2010: Anett Lauter; Annette Strumpf; Uwe Platzbecker; Johannes Schetelig; Martin Wermke; Jörgen Radke; Alexander Kiani; Gerd Wunderlich; Christian Thiede; Gerhard Ehninger; Jörg Kotzerke; Martin Bornhäuser
188Re anti-CD66 radioimmunotherapy combined with reduced-intensity conditioning and in-vivo T cell depletion in elderly patients undergoing allogeneic haematopoietic cell transplantation.
British journal of haematology 2010;148(6):910-7.
2010: Nicolaus Kröger; Avichai Shimoni; Georgia Schilling; Rainer Schwerdtfeger; Martin Bornhäuser; Arnon Nagler; Axel R Zander; Marion Heinzelmann; Ronald Brand; Gösta Gahrton; Curly Morris; Dietger Niederwieser; Theo de Witte
Unrelated stem cell transplantation after reduced intensity conditioning for patients with multiple myeloma relapsing after autologous transplantation.
British journal of haematology 2010;148(2):323-31.
2010: Friedrich Stölzel; Martin Wermke; Christoph Röllig; Christian Thiede; Uwe Platzbecker; Martin Bornhäuser
Mobilization of PML/RARalpha negative peripheral blood stem cells with a combination of G-CSF and CXCR4 blockade in relapsed acute promyelocytic leukemia pre-treated with arsenic trioxide.
Haematologica 2010;95(1):171-2.
2010: Tilman Rachner; Shiv K Singh; Michael Schoppet; Peggy Benad; Martin Bornhäuser; Volker Ellenrieder; Regina Ebert; Franz Jakob; Lorenz C Hofbauer
Zoledronic acid induces apoptosis and changes the TRAIL/OPG ratio in breast cancer cells.
Cancer letters 2010;287(1):109-16.
2009: Nicolaus Kröger; Ernst Holler; Guido Kobbe; Martin Bornhäuser; Rainer Schwerdtfeger; Herrad Baurmann; Arnon Nagler; Wolfgang Bethge; Matthias Stelljes; Lutz Uharek; Hannes Wandt; Andreas Burchert; Paolo Corradini; Jörg Schubert; Martin Kaufmann; Peter Dreger; Gerald G Wulf; Hermann Einsele; Tatjana Zabelina; Hans Michael Kvasnicka; Jürgen Thiele; Ronald Brand; Axel R Zander; Dietger Niederwieser; Theo M de Witte
Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Blood 2009;114(26):5264-70.
2009: Malte von Bonin; Alexander Kiani; Uwe Platzbecker; Johannes Schetelig; Kristina Hölig; Uta Oelschlägel; Christian Thiede; Gerhard Ehninger; Martin Bornhäuser
Third-party mesenchymal stem cells as part of the management of graft-failure after haploidentical stem cell transplantation.
Leukemia research 2009;33(12):e215-7.
2009: Roland Kronenberger; Eberhard Schleyer; Martin Bornhäuser; Gerhard Ehninger; Norbert Gattermann; Sabine Blum
Imatinib in breast milk.
Annals of hematology 2009;88(12):1265-6.
2009: F Philipp Seib; Marina Prewitz; Carsten Werner; Martin Bornhäuser
Matrix elasticity regulates the secretory profile of human bone marrow-derived multipotent mesenchymal stromal cells (MSCs).
Biochemical and biophysical research communications 2009;389(4):663-7.
2009: Martin Bornhäuser; Uta Oelschlaegel; Uwe Platzbecker; Gesine Bug; Karin Lutterbeck; Michael Kiehl; Johannes Schetelig; Alexander Kiani; Thomas Illmer; Markus Schaich; Catrin Theuser; Brigitte Mohr; C Brendel; Axel A Fauser; Stefan Klein; Hans Martin; Gerhard Ehninger; Christian Thiede
Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation.
Haematologica 2009;94(11):1613-7.
2009: P Bernstein; Martin Bornhäuser; Klaus-Peter Günther; M Stiehler
[Bone tissue engineering in clinical application : assessment of the current situation].
Der Orthopäde 2009;38(11):1029-37.
2009: Kristina Hölig; Michael Kramer; Frank Kroschinsky; Martin Bornhäuser; Thilo Mengling; Alexander H Schmidt; Claudia Rutt; Gerhard Ehninger
Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors.
Blood 2009;114(18):3757-63.
2009: Babette Lanfer; Friedrich P Seib; Uwe Freudenberg; Dimitar Stamov; Thomas Bley; Martin Bornhäuser; Carsten Werner
The growth and differentiation of mesenchymal stem and progenitor cells cultured on aligned collagen matrices.
Biomaterials 2009;30(30):5950-8.
2009: F Philipp Seib; Katrin Müller; Martina Franke; Milauscha Grimmer; Martin Bornhäuser; Carsten Werner
Engineered extracellular matrices modulate the expression profile and feeder properties of bone marrow-derived human multipotent mesenchymal stromal cells.
Tissue engineering. Part A 2009;15(10):3161-71.
2009: Gerhard Ehninger; Martin Bornhäuser
Allogeneic blood stem cell transplantation.
European journal of cancer (Oxford, England : 1990) 2009;45 Suppl 1():412-3.
2009: Jürgen Finke; Wolfgang A Bethge; Claudia Schmoor; Hellmut D Ottinger; Matthias Stelljes; Axel R Zander; Liisa Volin; Tapani Ruutu; Dominik A Heim; Rainer Schwerdtfeger; Karin Kolbe; Jiri Mayer; Johan A Maertens; Werner Linkesch; Ernst Holler; Vladimír Koza; Martin Bornhäuser; Hermann Einsele; Hans-Jochem Kolb; Hartmut Bertz; Matthias Egger; Olga Grishina; Gérard Socié
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.
The lancet oncology 2009;10(9):855-64.
2009: Rebekka Wehner; Diana Wehrum; Martin Bornhäuser; Senming Zhao; Knut Schäkel; Michael P Bachmann; Uwe Platzbecker; Gerhard Ehninger; E Peter Rieber; Marc Schmitz
Mesenchymal stem cells efficiently inhibit the proinflammatory properties of 6-sulfo LacNAc dendritic cells.
Haematologica 2009;94(8):1151-6.
2009: Fernando Ugarte; Martin Ryser; Sebastian Thieme; Fernando A Fierro; Katrin Navratiel; Martin Bornhäuser; Sebastian Brenner
Notch signaling enhances osteogenic differentiation while inhibiting adipogenesis in primary human bone marrow stromal cells.
Experimental hematology 2009;37(7):867-875.e1.
2009: Malte von Bonin; Kristina Hochauf; Stefan Monecke; Jörgen Radke; Christian Thiede; Martin Bornhäuser; Uwe Platzbecker; Gerhard Ehninger; Thomas Illmer
Rhinocerebral zygomycosis and subsequent treatment decisions in a young patient with AML.
Leukemia research 2009;33(7):e88-90.
2009: Ina Kurth; Katja Franke; Tilo Pompe; Martin Bornhäuser; Carsten Werner
Hematopoietic stem and progenitor cells in adhesive microcavities.
Integrative biology : quantitative biosciences from nano to macro 2009;1(5-6):427-34.
2009: F Philipp Seib; Martina Franke; Duohui Jing; Carsten Werner; Martin Bornhäuser
Endogenous bone morphogenetic proteins in human bone marrow-derived multipotent mesenchymal stromal cells.
European journal of cell biology 2009;88(5):257-71.
2009: José Tomás Egaña; Fernando Antonio Fierro; Stefan Krüger; Martin Bornhäuser; Ralf Huss; Sergio Lavandero; Hans-Günther Machens
Use of human mesenchymal cells to improve vascularization in a mouse model for scaffold-based dermal regeneration.
Tissue engineering. Part A 2009;15(5):1191-200.
2009: Michael Gerner; Kristina Hölig; Rebekka Wehner; Senming Zhao; Knut Schäkel; Michael Philipp Bachmann; E Peter Rieber; Martin Bornhäuser; Marc Schmitz
Extracorporeal photopheresis efficiently impairs the proinflammatory capacity of human 6-sulfo LacNAc dendritic cells.
Transplantation 2009;87(8):1134-9.
2009: Martin F Ryser; Sebastian Thieme; Martin Bornhäuser; Romy Lehmann; Sebastian Brenner
Serum albumin strongly influences SDF-1 dependent migration.
International journal of hematology 2009;89(3):269-75.
2009: M von Bonin; F Stölzel; A Goedecke; K Richter; N Wuschek; Kristina Hölig; Uwe Platzbecker; Thomas Illmer; Markus Schaich; Johannes Schetelig; A Kiani; Rainer Ordemann; Gerhard Ehninger; Marc Schmitz; Martin Bornhäuser
Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium.
Bone marrow transplantation 2009;43(3):245-51.
2009: Uwe Platzbecker; M von Bonin; Eray Goekkurt; Jörgen Radke; Marc Binder; Alexander Kiani; Jan Stoehlmacher; Johannes Schetelig; Christian Thiede; Gerhard Ehninger; Martin Bornhäuser
Graft-versus-host disease prophylaxis with everolimus and tacrolimus is associated with a high incidence of sinusoidal obstruction syndrome and microangiopathy: results of the EVTAC trial.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(1):101-8.
2008: Johannes Schetelig; Martin Bornhäuser; Christoph Schmid; Bernd Hertenstein; Rainer Schwerdtfeger; Hans Martin; Matthias Stelljes; Ute Hegenbart; Kerstin Schäfer-Eckart; Monika Füssel; Barbel Wiedemann; Christian Thiede; Joachim Kienast; Herrad Baurmann; Arnold Ganser; Hans-Jochem Kolb; Gerhard Ehninger
Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(32):5183-91.
2008: Uwe Platzbecker; Martin Bornhäuser; Ulrich Germing; Julian Stumpf; Bart L Scott; Nicolaus Kröger; Rainer Schwerdtfeger; Alexandra Böhm; Guido Kobbe; Catrin Theuser; Werner Rabitsch; Peter Valent; Mohamed L Sorror; Gerhard Ehninger; H Joachim Deeg
Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS).
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(11):1217-25.
2008: Martin F Ryser; Fernando Ugarte; Romy Lehmann; Martin Bornhäuser; Sebastian Brenner
S1P(1) overexpression stimulates S1P-dependent chemotaxis of human CD34+ hematopoietic progenitor cells but strongly inhibits SDF-1/CXCR4-dependent migration and in vivo homing.
Molecular immunology 2008;46(1):166-71.
2008: Johannes Schetelig; Anja van Biezen; Ronald Brand; Dolores Caballero; Rodrigo Martino; Maija Itala; José A García-Marco; Liisa Volin; Norbert Schmitz; Rainer Schwerdtfeger; Arnold Ganser; Francesco Onida; Brigitte Mohr; Stephan Stilgenbauer; Martin Bornhäuser; Theo de Witte; Peter Dreger
Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(31):5094-100.
2008: Stefan Pursche; Eberhard Schleyer; Malte von Bonin; Gerhard Ehninger; Samir Mustafa Said; Roland Prondzinsky; Thomas Illmer; Yanfeng Wang; Christian Hosius; Zariana Nikolova; Martin Bornhäuser; Gregor Dresemann
Influence of enzyme-inducing antiepileptic drugs on trough level of imatinib in glioblastoma patients.
Current clinical pharmacology 2008;3(3):198-203.
2008: Martin Bornhäuser; Thomas Illmer; Uta Oelschlaegel; Johannes Schetelig; Rainer Ordemann; Markus Schaich; Mathias Hänel; Ulrich Schuler; Christian Thiede; Alexander Kiani; Uwe Platzbecker; Gerhard Ehninger
Gemtuzumab ozogamicin as part of reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in patients with relapsed acute myeloid leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(17):5585-93.
2008: Martin F Ryser; Fernando Ugarte; Sebastian Thieme; Martin Bornhäuser; Angela Roesen-Wolff; Sebastian Brenner
mRNA transfection of CXCR4-GFP fusion--simply generated by PCR-results in efficient migration of primary human mesenchymal stem cells.
Tissue engineering. Part C, Methods 2008;14(3):179-84.
2008: Uwe Platzbecker; Marc Binder; Christoph Schmid; Claudia Rutt; Gerhard Ehninger; Martin Bornhäuser
Second donation of hematopoietic stem cells from unrelated donors for patients with relapse or graft failure after allogeneic transplantation.
Haematologica 2008;93(8):1276-8.
2008: Kristin Alberti; Ryan E Davey; Kento Onishi; Sophia George; Katrin Salchert; F Philipp Seib; Martin Bornhäuser; Tilo Pompe; Andras Nagy; Carsten Werner; Peter W Zandstra
Functional immobilization of signaling proteins enables control of stem cell fate.
Nature methods 2008;5(7):645-50.
2008: Georgia Schilling; T Hansen; Avichai Shimoni; Tatjana Zabelina; J-A Pérez-Simón; J-A Simon-Perez; N C Gutierrez; W Bethge; P Liebisch; Rainer Schwerdtfeger; Martin Bornhäuser; S Otterstetter; E M M Penas; Judith Dierlamm; Francis Ayuk; Djordje Atanackovic; Ulrike Bacher; Carsten Bokemeyer; A Zander; J San Miguel; J S Miguel; Arnon Nagler; Nicolaus Kröger
Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma.
Leukemia 2008;22(6):1250-5.
2008: Astrid Schulze; Holger Schirutschke; Uta Oelschlägel; Marc Schmitz; Monika Füssel; Ralf Wassmuth; Gerhard Ehninger; Martin Bornhäuser; Uwe Platzbecker
Altered phenotype of natural killer cell subsets after haploidentical stem cell transplantation.
Experimental hematology 2008;36(4):378-89.
2008: Nicola Bauer; Ana-Violeta Fonseca; Mareike Florek; Daniel Freund; József Jászai; Martin Bornhäuser; Christine A Fargeas; Denis Corbeil
New insights into the cell biology of hematopoietic progenitors by studying prominin-1 (CD133).
Cells, tissues, organs 2008;188(1-2):127-38.
2008: Wolfgang A Bethge; Christoph Faul; Martin Bornhäuser; Gernot Stuhler; Dietrich W Beelen; Peter Lang; Matthias Stelljes; Wichard Vogel; Matthias Hägele; Rupert Handgretinger; Lothar Kanz
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: an update.
Blood cells, molecules & diseases 2008;40(1):13-9.
2007: Beate Gleissner; Richard Schlenk; Martin Bornhäuser; Wolfgang E Berdel
Gemtuzumab ozogamicin (mylotarg) for the treatment of acute myeloid leukemia--ongoing trials.
Onkologie 2007;30(12):657-62.
2007: Nicolaus Kröger; Jürgen Thiele; Axel Zander; Rainer Schwerdtfeger; Guido Kobbe; Martin Bornhäuser; Wolfgang Bethge; Jörg Schubert; Theo de Witte; Hans Michael Kvasnicka
Rapid regression of bone marrow fibrosis after dose-reduced allogeneic stem cell transplantation in patients with primary myelofibrosis.
Experimental hematology 2007;35(11):1719-22.
2007: Christoph Schmid; Myriam Labopin; Arnon Nagler; Martin Bornhäuser; Jürgen Finke; AB Fassas; Liisa Volin; Günham Gürman; Johan Maertens; Pierre Bordigoni; Ernst Holler; Gerhard Ehninger; Emmanuelle Polge; Norbert-Claude Gorin; Hans-Jochem Kolb; Vanderson Rocha
Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(31):4938-45.
2007: Uwe Platzbecker; B Mohr; M von Bonin; M Binder; Johannes Schetelig; Gerhard Ehninger; Martin Bornhäuser
Lenalidomide as induction therapy before allogeneic stem cell transplantation in a patient with proliferative CMML-2 and del(5q) not involving the EGR1 locus.
Leukemia 2007;21(11):2384-5.
2007: Uwe Platzbecker; Gerhard Ehninger; Martin Bornhäuser
Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem-cell transplantation.
Blood 2007;110(8):3083; author reply 3083-4.
2007: Susanne H C Baumeister; Kristina Hölig; Martin Bornhäuser; Michael Meurer; E Peter Rieber; Knut Schäkel
G-CSF mobilizes slanDCs (6-sulfo LacNAc+ dendritic cells) with a high proinflammatory capacity.
Blood 2007;110(8):3078-81.
2007: Martin Bornhäuser; B Mohr; Uta Oelschlaegel; P Bornhäuser; S Jacki; Gerhard Ehninger; Christian Thiede
Concurrent JAK2(V617F) mutation and BCR-ABL translocation within committed myeloid progenitors in myelofibrosis.
Leukemia 2007;21(8):1824-6.
2007: C Straube; Rebekka Wehner; M Wendisch; Martin Bornhäuser; Michael Bachmann; E Peter Rieber; Marc Schmitz
Bortezomib significantly impairs the immunostimulatory capacity of human myeloid blood dendritic cells.
Leukemia 2007;21(7):1464-71.
2007: Thomas Illmer; Hans-M Thiede; Christian Thiede; Martin Bornhäuser; Markus Schaich; Eberhard Schleyer; Gerhard Ehninger
A highly sensitive method for the detection of PKC412 (CGP41251) and its metabolites by high-performance liquid chromatography.
Journal of pharmacological and toxicological methods 2007;56(1):23-7.
2007: Christoph Pöhlmann; Johannes Schetelig; Ulrike Reuner; Martin Bornhäuser; Thomas Illmer; Alexander Kiani; Gerhard Ehninger; Enno Jacobs; Jacques Rohayem
Cidofovir and foscarnet for treatment of human herpesvirus 6 encephalitis in a neutropenic stem cell transplant recipient.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(12):e118-20.
2007: F Fierro; Thomas Illmer; D Jing; Eberhard Schleyer; Gerhard Ehninger; Sabine Boxberger; Martin Bornhäuser
Inhibition of platelet-derived growth factor receptorbeta by imatinib mesylate suppresses proliferation and alters differentiation of human mesenchymal stem cells in vitro.
Cell proliferation 2007;40(3):355-66.
2007: Caroline Pabst; Holger Schirutschke; Gerhard Ehninger; Martin Bornhäuser; Uwe Platzbecker
The graft content of donor T cells expressing gamma delta TCR+ and CD4+foxp3+ predicts the risk of acute graft versus host disease after transplantation of allogeneic peripheral blood stem cells from unrelated donors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(10):2916-22.
2007: Susanne Auffermann-Gretzinger; Lars Eger; Johannes Schetelig; Martin Bornhäuser; Falk Heidenreich; Gerhard Ehninger
Alemtuzumab depletes dendritic cells more effectively in blood than in skin: a pilot study in patients with chronic lymphocytic leukemia.
Transplantation 2007;83(9):1268-72.
2007: Alexander Kiani; Hanna Kuithan; Friederike Kuithan; Satu Kyttälä; Ivonne Habermann; Achim Temme; Martin Bornhäuser; Gerhard Ehninger
Expression analysis of nuclear factor of activated T cells (NFAT) during myeloid differentiation of CD34+ cells: regulation of Fas ligand gene expression in megakaryocytes.
Experimental hematology 2007;35(5):757-70.
2007: Martin Bornhäuser; Thomas Illmer; Markus Schaich; Silke Soucek; Gerhard Ehninger; Christian Thiede
Improved outcome after stem-cell transplantation in FLT3/ITD-positive AML.
Blood 2007;109(5):2264-5; author reply 2265.
2007: Katja Franke; Tilo Pompe; Martin Bornhäuser; Carsten Werner
Engineered matrix coatings to modulate the adhesion of CD133+ human hematopoietic progenitor cells.
Biomaterials 2007;28(5):836-43.
2007: Nicolaus Kröger; Anita Badbaran; Ernst Holler; Joachim Hahn; Guido Kobbe; Martin Bornhäuser; Andreas Reiter; Tatjana Zabelina; Axel R Zander; Boris Fehse
Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis.
Blood 2007;109(3):1316-21.
2006: Daniel Freund; Nicola Bauer; Sabine Boxberger; Silvia Feldmann; Uwe Streller; Gerhard Ehninger; Carsten Werner; Martin Bornhäuser; Joachim Oswald; Denis Corbeil
Polarization of human hematopoietic progenitors during contact with multipotent mesenchymal stromal cells: effects on proliferation and clonogenicity.
Stem cells and development 2006;15(6):815-29.
2006: Rebekka Wehner; M Wendisch; Knut Schäkel; Martin Bornhäuser; Uwe Platzbecker; B Mohr; Achim Temme; Michael Bachmann; E Peter Rieber; Marc Schmitz
Imatinib mesylate does not impair the immunogenicity of human myeloid blood dendritic cells.
Leukemia 2006;20(9):1629-32.
2006: Barbara Wassmann; Heike Pfeifer; Nicola Goekbuget; Dietrich W Beelen; Joachim Beck; Matthias Stelljes; Martin Bornhäuser; Albrecht Reichle; Jolanta B Perz; Rainer Haas; Arnold Ganser; Mathias Schmid; Lothar Kanz; Georg Lenz; Martin Kaufmann; Anja Binckebanck; Patrick Brück; Regina Reutzel; Harald Gschaidmeier; Stefan Schwartz; Dieter Hoelzer; Oliver G Ottmann
Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).
Blood 2006;108(5):1469-77.
2006: Frank Kroschinsky; Kristina Hölig; Uwe Platzbecker; Kirsten Poppe-Thiede; Rainer Ordemann; Matthias Blechschmidt; Uta Oelschlaegel; Markus Schaich; Mathias Hänel; Martin Bornhäuser; Gerhard Ehninger
Efficacy of single-dose pegfilgrastim after chemotherapy for the mobilization of autologous peripheral blood stem cells in patients with malignant lymphoma or multiple myeloma.
Transfusion 2006;46(8):1417-23.
2006: Daniel Freund; Joachim Oswald; Silvia Feldmann; Gerhard Ehninger; Denis Corbeil; Martin Bornhäuser
Comparative analysis of proliferative potential and clonogenicity of MACS-immunomagnetic isolated CD34+ and CD133+ blood stem cells derived from a single donor.
Cell proliferation 2006;39(4):325-32.
2006: Katharine C Hsu; Ted Gooley; Mari Malkki; Clara Pinto-Agnello; Bo Dupont; Jean-Denis Bignon; Martin Bornhäuser; Frank Christiansen; Alois Gratwohl; Yasuo Morishima; Machteld Oudshoorn; Olle Ringden; Jon van Rood; Effie W Petersdorf
KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(8):828-36.
2006: Uwe Platzbecker; Christian Thiede; M Füssel; G Geissler; Thomas Illmer; Brigitte Mohr; Mathias Hänel; R Mahlberg; U Krümpelmann; F Weissinger; Markus Schaich; Catrin Theuser; Gerhard Ehninger; Martin Bornhäuser
Reduced intensity conditioning allows for up-front allogeneic hematopoietic stem cell transplantation after cytoreductive induction therapy in newly-diagnosed high-risk acute myeloid leukemia.
Leukemia 2006;20(4):707-14.
2006: Hermann Einsele; Pierre Reusser; Martin Bornhäuser; Peter Kalhs; Gerhard Ehninger; Holger Hebart; Yves Chalandon; Nicolaus Kröger; Bernd Hertenstein; Frank Rohde
Oral valganciclovir leads to higher exposure to ganciclovir than intravenous ganciclovir in patients following allogeneic stem cell transplantation.
Blood 2006;107(7):3002-8.
2006: Susanne Auffermann-Gretzinger; Lars Eger; Martin Bornhäuser; Knut Schäkel; Uta Oelschlaegel; Markus Schaich; Thomas Illmer; Christian Thiede; Gerhard Ehninger
Fast appearance of donor dendritic cells in human skin: dynamics of skin and blood dendritic cells after allogeneic hematopoietic cell transplantation.
Transplantation 2006;81(6):866-73.
2006: Joachim Oswald; Christine Steudel; Katrin Salchert; Brigitte Joergensen; Christian Thiede; Gerhard Ehninger; Carsten Werner; Martin Bornhäuser
Gene-expression profiling of CD34+ hematopoietic cells expanded in a collagen I matrix.
Stem cells (Dayton, Ohio) 2006;24(3):494-500.
2006: Jana Babatz; Christoph Röllig; Bärbel Löbel; Gunnar Folprecht; Michael Haack; Heinrich Günther; Claus-Henning Köhne; Gerhard Ehninger; Marc Schmitz; Martin Bornhäuser
Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells.
Cancer immunology, immunotherapy : CII 2006;55(3):268-76.
2006: Kathrin Rieger; Christoph Loddenkemper; Jochen Maul; Thomas Fietz; Daniel Wolff; Harald Terpe; Beate Steiner; Erika Berg; Stephan Miehlke; Martin Bornhäuser; Thomas Schneider; Martin Zeitz; Harald Stein; Eckhard Thiel; Rainer Duchmann; Lutz Uharek
Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD.
Blood 2006;107(4):1717-23.
2006: Martin Bornhäuser; Nicolaus Kröger; Rainer Schwerdtfeger; Karin Schafer-Eckart; Herbert G Sayer; Christoph Scheid; Matthias Stelljes; Joachim Kienast; Peter Mundhenk; Stefan Fruehauf; Michael Kiehl; Hannes Wandt; Catrin Theuser; Gerhard Ehninger; Axel R Zander
Allogeneic haematopoietic cell transplantation for chronic myelogenous leukaemia in the era of imatinib: a retrospective multicentre study.
European journal of haematology 2006;76(1):9-17.
2005: D Strodtbeck; Martin Bornhäuser; Mathias Hänel; L Lerche; Markus Schaich; Thomas Illmer; Christian Thiede; G Geissler; R Herbst; Gerhard Ehninger; Uwe Platzbecker
Graft clonogenicity and intensity of pre-treatment: factors affecting outcome of autologous peripheral hematopoietic cell transplantation in patients with acute myeloid leukemia in first remission.
Bone marrow transplantation 2005;36(12):1083-8.
2005: Johannes Schetelig; Alexander Kiani; Marc Schmitz; Gerhard Ehninger; Martin Bornhäuser
T cell-mediated graft-versus-leukemia reactions after allogeneic stem cell transplantation.
Cancer immunology, immunotherapy : CII 2005;54(11):1043-58.
2005: Georg Hess; Donald Bunjes; Wolfgang Siegert; Rainer Schwerdtfeger; Georg Ledderose; Barbara Wassmann; Guido Kobbe; Martin Bornhäuser; Andreas Hochhaus; Andrew J Ullmann; Thomas Kindler; Ulrike Haus; Harald Gschaidmeier; Christoph Huber; Thomas Fischer
Sustained complete molecular remissions after treatment with imatinib-mesylate in patients with failure after allogeneic stem cell transplantation for chronic myelogenous leukemia: results of a prospective phase II open-label multicenter study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(30):7583-93.
2005: Bernd Hertenstein; Lothar Hambach; Andrea Bacigalupo; Norbert Schmitz; Shaun McCann; Shimon Slavin; Alois Gratwohl; Augustin Ferrant; Ahmet H Elmaagacli; Rainer Schwertfeger; Anna Locasciulli; Axel Zander; Martin Bornhäuser; Dietger Niederwieser; Tapani Ruutu
Development of leukemia in donor cells after allogeneic stem cell transplantation--a survey of the European Group for Blood and Marrow Transplantation (EBMT).
Haematologica 2005;90(7):969-75.
2005: Martin Bornhäuser; Stefan Pursche; Malte Bonin; Jens Freiberg-Richter; Andreas Jenke; Thomas Illmer; Gerhard Ehninger; Eberhard Schleyer
Elimination of imatinib mesylate and its metabolite N-desmethyl-imatinib.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(16):3855-6; author reply 3857-8.
2005: Nicolaus Kröger; Bronwen Shaw; Simona Iacobelli; Tatjana Zabelina; Karl S Peggs; Avichai Shimoni; Arnon Nagler; Thomas Binder; Thomas Eiermann; Alejandro Madrigal; Rainer Schwerdtfeger; Michael Kiehl; Herbert G Sayer; Jörg Beyer; Martin Bornhäuser; Francis Ayuk; Axel R Zander; David I Marks
Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma.
British journal of haematology 2005;129(5):631-43.
2005: Johannes Schetelig; Astrid Breitschaft; Nicolaus Kröger; Tatjana Zabelina; Wolfram Ebell; Martin Bornhäuser; Astrid Haack; Gerhard Ehninger; Abdulgabar Salama; Wolfgang Siegert
After major ABO-mismatched allogeneic hematopoietic progenitor cell transplantation, erythroid engraftment occurs later in patients with donor blood group A than donor blood group B.
Transfusion 2005;45(5):779-87.
2005: Marc Schmitz; Senming Zhao; Yvonne Deuse; Knut Schäkel; Rebekka Wehner; Hanka Wöhner; Kristina Hölig; Florian Wienforth; Andrea Kiessling; Martin Bornhäuser; Achim Temme; Michael A Rieger; Bernd Weigle; Michael Bachmann; E Peter Rieber
Tumoricidal potential of native blood dendritic cells: direct tumor cell killing and activation of NK cell-mediated cytotoxicity.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(7):4127-34.
2005: Andreas Jenke; Jens Freiberg-Richter; C Johne; H Knoth; Eberhard Schleyer; Gerhard Ehninger; Martin Bornhäuser
Targeting once-daily intravenous busulfan in combination with fludarabine before allogeneic hematopoietic cell transplantation.
Bone marrow transplantation 2005;35(6):627-8.
2005: Uwe Platzbecker; M Haase; R Herbst; Annette Hänel; K Voigtmann; Christian Thiede; Brigitte Mohr; Eberhard Schleyer; Traugott Leopold; Matthias Orth; Mathias Hänel; Gerhard Ehninger; Martin Bornhäuser
Activity of sirolimus in patients with myelodysplastic syndrome--results of a pilot study.
British journal of haematology 2005;128(5):625-30.
2005: Uwe Platzbecker; Martin Bornhäuser; Kristin Zimmer; Linda Lerche; Claudia Rutt; Gerhard Ehninger; Kristina Hölig
Second donation of granulocyte-colony-stimulating factor-mobilized peripheral blood progenitor cells: risk factors associated with a low yield of CD34+ cells.
Transfusion 2005;45(1):11-5.
2005: Andreas Jenke; Jens Freiberg-Richter; S Wilhelm; M Freund; Ulf Renner; Martin Bornhäuser; Eberhard Schleyer; Gerhard Ehninger; Ulrich Schuler
Accidental busulfan overdose during conditioning for stem cell transplantation.
Bone marrow transplantation 2005;35(2):125-8.
2005: Martin Bornhäuser; Lars Eger; Uta Oelschlaegel; Susanne Auffermann-Gretzinger; Alexander Kiani; Johannes Schetelig; Thomas Illmer; Markus Schaich; D Corbeil; Christian Thiede; Gerhard Ehninger
Rapid reconstitution of dendritic cells after allogeneic transplantation of CD133+ selected hematopoietic stem cells.
Leukemia 2005;19(1):161-5.
2004: Brigitte Mohr; R Koch; Christian Thiede; Frank Kroschinsky; Gerhard Ehninger; Martin Bornhäuser
CD34+ cell dose, conditioning regimen and prior chemotherapy: factors with significant impact on the early kinetics of donor chimerism after allogeneic hematopoietic cell transplantation.
Bone marrow transplantation 2004;34(11):949-54.
2004: Alexander Kiani; Ivonne Habermann; Michael Haase; Silvia Feldmann; Sabine Boxberger; Maria A Sanchez-Fernandez; Christian Thiede; Martin Bornhäuser; Gerhard Ehninger
Expression and regulation of NFAT (nuclear factors of activated T cells) in human CD34+ cells: down-regulation upon myeloid differentiation.
Journal of leukocyte biology 2004;76(5):1057-65.
2004: Martin Bornhäuser; Rainer Schwerdtfeger; Hilmar Martin; Karl-Heinz Frank; Catrin Theuser; Gerhard Ehninger
Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors.
Blood 2004;103(7):2860-1; author reply 2862.
2004: Philipp le Coutre; Karl-Anton Kreuzer; Stefan Pursche; Malte v Bonin; Traugott Leopold; Gökben Baskaynak; Bernd Dörken; Gerhard Ehninger; Oliver G Ottmann; Andreas Jenke; Martin Bornhäuser; Eberhard Schleyer
Pharmacokinetics and cellular uptake of imatinib and its main metabolite CGP74588.
Cancer chemotherapy and pharmacology 2004;53(4):313-23.
2004: Uwe Platzbecker; Gerhard Ehninger; Martin Bornhäuser
Allogeneic transplantation of CD34+ selected hematopoietic cells--clinical problems and current challenges.
Leukemia & lymphoma 2004;45(3):447-53.
2004: Martin Bornhäuser; Ulrich Klenk; Christoph Röllig; Michael Haack; Jana Babatz; Olaf Koch; Gustavo B Baretton; Gerhard Ehninger
Mixed response after allogeneic haemopoietic-cell transplantation for metastatic renal-cell carcinoma.
The lancet oncology 2004;5(3):191-2.
2004: Johannes Schetelig; Martin Bornhäuser; Michael Kiehl; Rainer Schwerdtfeger; Nicolaus Kröger; Volker Runde; Tatjana Zabelina; Thomas K Held; Christian Thiede; Axel A Fauser; D Beelen; Axel Zander; Gerhard Ehninger; Wolfgang Siegert
Reduced-intensity conditioning with busulfan and fludarabine with or without antithymocyte globulin in HLA-identical sibling transplantation--a retrospective analysis.
Bone marrow transplantation 2004;33(5):483-90.
2004: Joachim Oswald; Birgitte Jørgensen; Tilo Pompe; Fritz Kobe; Katrin Salchert; Martin Bornhäuser; Gerhard Ehninger; Carsten Werner
Comparison of flow cytometry and laser scanning cytometry for the analysis of CD34+ hematopoietic stem cells.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2004;57(2):100-7.
2004: Christian Thiede; Martin Bornhäuser; Gerhard Ehninger
Evaluation of STR informativity for chimerism testing--comparative analysis of 27 STR systems in 203 matched related donor recipient pairs.
Leukemia 2004;18(2):248-54.
2004: Eberhard Schleyer; Stefan Pursche; Claus-Henning Köhne; Ulrich Schuler; Ulf Renner; Harald Gschaidmeier; Jens Freiberg-Richter; Traugott Leopold; Andreas Jenke; M Bonin; T Bergemann; Philipp le Coutre; M Gruner; Martin Bornhäuser; Oliver G Ottmann; Gerhard Ehninger
Liquid chromatographic method for detection and quantitation of STI-571 and its main metabolite N-desmethyl-STI in plasma, urine, cerebrospinal fluid, culture medium and cell preparations.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2004;799(1):23-36.
2004: Christian Thiede; Martin Bornhäuser; Gerhard Ehninger
Strategies and clinical implications of chimerism diagnostics after allogeneic hematopoietic stem cell transplantation.
Acta haematologica 2004;112(1-2):16-23.
2004: Joachim Oswald; Sabine Boxberger; Birgitte Jørgensen; Silvia Feldmann; Gerhard Ehninger; Martin Bornhäuser; Carsten Werner
Mesenchymal stem cells can be differentiated into endothelial cells in vitro.
Stem cells (Dayton, Ohio) 2004;22(3):377-84.
2004: Martin Bornhäuser; Thomas Illmer; Philipp le Coutre; J Pursche; M von Bonin; Jens Freiberg-Richter; Markus Schaich; Uwe Platzbecker; Christian Thiede; Oliver G Ottmann; Ch Köhne; Jan Braess; Gerhard Ehninger; Eberhard Schleyer
Imatinib mesylate selectively influences the cellular metabolism of cytarabine in BCR/ABL negative leukemia cell lines and normal CD34+ progenitor cells.
Annals of hematology 2004;83 Suppl 1():S61-4.
2004: Frank Kroschinsky; Eberhard Schleyer; Ulf Renner; Claudia Schimming; Christoph Schimmelpfennig; Martin Bornhäuser; Thomas Illmer; Lorenz Trümper; Gerhard Ehninger; Markus Schaich
Increased myelotoxicity of idarubicin: is there a pharmacological basis? Results of a pharmacokinetic and an in vitro cytotoxicity study.
Cancer chemotherapy and pharmacology 2004;53(1):61-7.
2003: Jana Babatz; Christoph Röllig; U Oelschlägel; S Zhao; Gerhard Ehninger; Marc Schmitz; Martin Bornhäuser
Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study.
Journal of hematotherapy & stem cell research 2003;12(5):515-23.
2003: Uwe Platzbecker; Gerhard Ehninger; Norbert Schmitz; Martin Bornhäuser
Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation in myeloid diseases.
Annals of hematology 2003;82(8):463-8.
2003: Axel R Zander; Nicolaus Kröger; Michael Schleuning; J Finke; Tatjana Zabelina; Dietrich W Beelen; Rainer Schwerdtfeger; H Baurmann; Martin Bornhäuser; Gerhard Ehninger; Axel A Fauser; Michael Kiehl; Rudolf Trenschel; Hellmut D Ottinger; H Bertz; J Berger; Hans-Jochem Kolb; Ulrich W Schaefer
ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML).
Bone marrow transplantation 2003;32(4):355-61.
2003: Herbert G Sayer; Matthias Kröger; Jörg Beyer; Michael Kiehl; S A Klein; K Schaefer-Eckart; Rainer Schwerdtfeger; Wolfgang Siegert; Volker Runde; Catrin Theuser; H Martin; Johannes Schetelig; D W Beelen; Axel A Fauser; Joachim Kienast; Klaus Höffken; Gerhard Ehninger; Martin Bornhäuser
Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor.
Bone marrow transplantation 2003;31(12):1089-95.
2003: Nicolaus Kröger; Martin Bornhäuser; Gerhard Ehninger; Rainer Schwerdtfeger; H Biersack; Herbert G Sayer; Hannes Wandt; K Schäfer-Eckardt; Jörg Beyer; Michael Kiehl; Axel R Zander
Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
Annals of hematology 2003;82(6):336-42.
2003: Markus Schaich; Knut Schäkel; Thomas Illmer; Gerhard Ehninger; Martin Bornhäuser
Severe epidermal necrolysis after treatment with imatinib and consecutive allogeneic hematopoietic stem cell transplantation.
Annals of hematology 2003;82(5):303-4.
2003: Barbara Wassmann; Urban J Scheuring; Christian Thiede; Heike Pfeifer; Martin Bornhäuser; F Griesinger; Andreas Hochhaus; Eberhard Schleyer; Harald Gschaidmeier; Dieter Hoelzer; Oliver G Ottmann
Stable molecular remission induced by imatinib mesylate (STI571) in a patient with CML lymphoid blast crisis relapsing after allogeneic stem cell transplantation.
Bone marrow transplantation 2003;31(7):611-4.
2003: Mathias Hänel; Christian Thiede; Anett Helwig; Gabriele Prange-Krex; Jana Babatz; Michael Haack; Frank Kroschinsky; Sebastian Fetscher; Gerhard Ehninger; Martin Bornhäuser
Successful combination of anti-CD33 antibody (gemtuzumab ozogamicin) and minimal conditioning before second allografting in recurrent acute myeloid leukaemia.
British journal of haematology 2003;120(6):1093-4.
2003: Mathias Hänel; Martin Bornhäuser; J Müller; Christian Thiede; Gerhard Ehninger; Frank Kroschinsky
Evidence for a graft-versus-tumor effect in refractory ovarian cancer.
Journal of cancer research and clinical oncology 2003;129(1):12-6.
2003: Martin Bornhäuser
Ex vivo expansion of umbilical cord blood cells on feeder layers.
Methods in molecular biology (Clifton, N.J.) 2003;215():341-9.
2002: Renate Arnold; Gero Massenkeil; Martin Bornhäuser; Gerhard Ehninger; Dietrich W Beelen; Axel A Fauser; Ute Hegenbart; Bernd Hertenstein; A D Ho; Wolfgang Knauf; H J Kolb; K Kolbe; Herbert G Sayer; Rainer Schwerdtfeger; Hannes Wandt; Dieter Hoelzer
Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced disease.
Leukemia 2002;16(12):2423-8.
2002: Michael Kiehl; K Schäfer-Eckart; Matthias Kröger; Martin Bornhäuser; Nadezda Basara; Igor Wolfgang Blau; Joachim Kienast; Axel A Fauser; Gerhard Ehninger; V W Armstrong; Maria Shipkova
Mycophenolate mofetil for the prophylaxis of acute graft-versus-host disease in stem cell transplant recipients.
Transplantation proceedings 2002;34(7):2922-4.
2002: Marc Schmitz; Martin Bornhäuser; Detlef Ockert; E Peter Rieber
Cancer immunotherapy: novel strategies and clinical experiences.
Trends in immunology 2002;23(9):428-9.
2002: Martin Bornhäuser; Uwe Platzbecker; Catrin Theuser; Kristina Hölig; Gerhard Ehninger
CD34+-enriched peripheral blood progenitor cells from unrelated donors for allografting of adult patients: high risk of graft failure, infection and relapse despite donor lymphocyte add-back.
British journal of haematology 2002;118(4):1095-103.
2002: Marc Schmitz; Senming Zhao; Knut Schäkel; Martin Bornhäuser; Detlef Ockert; E Peter Rieber
Native human blood dendritic cells as potent effectors in antibody-dependent cellular cytotoxicity.
Blood 2002;100(4):1502-4.
2002: Christian Thiede; Christine Steudel; Brigitte Mohr; Markus Schaich; Ulrike Schäkel; Uwe Platzbecker; Martin Wermke; Martin Bornhäuser; Markus Ritter; Andreas Neubauer; Gerhard Ehninger; Thomas Illmer
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis.
Blood 2002;99(12):4326-35.
2002: Johannes Schetelig; Nicolaus Kröger; Thomas K Held; Christian Thiede; Andreas Krusch; Tatjana Zabelina; Marc Dubiel; Oliver Rick; Martin Bornhäuser; Gerhard Ehninger; Axel R Zander; Wolfgang Siegert
Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host disease.
Haematologica 2002;87(3):299-305.
2002: Mathias Hänel; Nicolaus Kröger; Stefan Sonnenberg; Martin Bornhäuser; William H Krüger; Frank Kroschinsky; Annette Hänel; Bernd Metzner; Josef Birkmann; B Schmid; MM Hoffknecht; Friedrich Fiedler; Gerhard Ehninger; Axel R Zander
Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma.
Annals of hematology 2002;81(2):96-102.
2002: Johannes Schetelig; Christian Thiede; Martin Bornhäuser; Rainer Schwerdtfeger; Michael Kiehl; Jörg Beyer; Nicolaus Kröger; M Hensel; christian scheffold; A D Ho; Joachim Kienast; Andreas Neubauer; Axel R Zander; Axel A Fauser; Gerhard Ehninger; Wolfgang Siegert
Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemia.
Annals of hematology 2002;81 Suppl 2():S47-8.
2002: Christian Thiede; K Lutterbeck; U Oelschlägel; Michael Kiehl; Christine Steudel; Uwe Platzbecker; C Brendel; Axel A Fauser; Andreas Neubauer; Gerhard Ehninger; Martin Bornhäuser
Detection of relapse by sequential monitoring of chimerism in circulating CD34+ cells.
Annals of hematology 2002;81 Suppl 2():S27-8.
2002: Christoph Röllig; Jana Babatz; I Wagner; A Maiwald; V Schwarze; Gerhard Ehninger; Martin Bornhäuser
Thawing of cryopreserved mobilized peripheral blood--comparison between waterbath and dry warming device.
Cytotherapy 2002;4(6):551-5.
2001: Uwe Platzbecker; Thomas Illmer; Markus Schaich; Jens Freiberg-Richter; Anett Helwig; R Plettig; Andreas Jenke; Gerhard Ehninger; Martin Bornhäuser
Double lumen port access in patients receiving allogeneic blood stem cell transplantation.
Bone marrow transplantation 2001;28(11):1067-72.
2001: Martin Bornhäuser; Michael Kiehl; Wolfgang Siegert; Johannes Schetelig; Bernd Hertenstein; H Martin; Rainer Schwerdtfeger; Herbert G Sayer; Volker Runde; Nicolaus Kröger; Catrin Theuser; Gerhard Ehninger
Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: a retrospective analysis.
British journal of haematology 2001;115(1):119-24.
2001: Ulrich Schuler; Ulf Renner; Frank Kroschinsky; C Johne; Andreas Jenke; Ralph Naumann; Martin Bornhäuser; H Joachim Deeg; Gerhard Ehninger
Intravenous busulphan for conditioning before autologous or allogeneic human blood stem cell transplantation.
British journal of haematology 2001;114(4):944-50.
2001: Martin Bornhäuser; Christian Thiede; Uwe Platzbecker; Andreas Jenke; Anett Helwig; R Plettig; Jens Freiberg-Richter; Christoph Röllig; G Geissler; K Lutterbeck; U Oelschlagel; Gerhard Ehninger
Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(8):2254-62.
2001: Brigitte Mohr; Martin Bornhäuser; Uwe Platzbecker; Jens Freiberg-Richter; Ralph Naumann; Gabriele Prange-Krex; J Mohm; Frank Kroschinsky; Gerhard Ehninger; Christian Thiede
Problems with interphase fluorescence in situ hybridization in detecting BCR/ABL-positive cells in some patients using a novel technique with extra signals.
Cancer genetics and cytogenetics 2001;127(2):111-7.
2001: Andreas Jenke; Ulf Renner; M Richte; Jens Freiberg-Richter; Uwe Platzbecker; Anett Helwig; HM Thiede; K Schäfer-Eckart; Gerhard Ehninger; Martin Bornhäuser
Pharmacokinetics of intravenous mycophenolate mofetil after allogeneic blood stem cell transplantation.
Clinical transplantation 2001;15(3):176-84.
2001: Uwe Platzbecker; D Bandt; Christian Thiede; Anett Helwig; Jens Freiberg-Richter; Ulrich Schuler; R Plettig; G Geissler; A Rethwilm; Gerhard Ehninger; Martin Bornhäuser
Successful preemptive cidofovir treatment for CMV antigenemia after dose-reduced conditioning and allogeneic blood stem cell transplantation.
Transplantation 2001;71(7):880-5.
2001: C Schimmelpfennig; Ralph Naumann; T Zuberbier; Rainer Ordemann; H Baurmann; Jörg Beyer; Wolfgang Siegert; Martin Bornhäuser; Gerhard Ehninger
Skin involvement as the first manifestation of systemic aspergillosis in patients after allogeneic hematopoietic cell transplantation.
Bone marrow transplantation 2001;27(7):753-5.
2001: Uwe Platzbecker; Christian Thiede; Jens Freiberg-Richter; Anett Helwig; Brigitte Mohr; G Prange; M Füssel; T Köhler; Gerhard Ehninger; Martin Bornhäuser
Treatment of relapsing leukemia after allogeneic blood stem cell transplantation by using dose-reduced conditioning followed by donor blood stem cells and GM-CSF.
Annals of hematology 2001;80(3):144-9.
2001: Uwe Platzbecker; Christian Thiede; Jens Freiberg-Richter; Christoph Röllig; Anett Helwig; Ulrike Schäkel; Brigitte Mohr; Markus Schaich; Gerhard Ehninger; Martin Bornhäuser
Early allogeneic blood stem cell transplantation after modified conditioning therapy during marrow aplasia: stable remission in high-risk acute myeloid leukemia.
Bone marrow transplantation 2001;27(5):543-6.
2001: Uwe Platzbecker; Gabriele Prange-Krex; Martin Bornhäuser; R Koch; Silke Soucek; P Aikele; A Haack; C Haag; Ulrich Schuler; A Berndt; Claudia Rutt; Gerhard Ehninger; Kristina Hölig
Spleen enlargement in healthy donors during G-CSF mobilization of PBPCs.
Transfusion 2001;41(2):184-9.
2001: Christian Thiede; Martin Bornhäuser; U Oelschlägel; C Brendel; R Leo; H Daxberger; Brigitte Mohr; M Florek; Frank Kroschinsky; G Geissler; Ralph Naumann; Markus Ritter; Gabriele Prange-Krex; Thomas Lion; Andreas Neubauer; Gerhard Ehninger
Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers.
Leukemia 2001;15(2):293-302.
2001: Uwe Platzbecker; K Klingel; Christian Thiede; Jens Freiberg-Richter; D Schuh; Gerhard Ehninger; R Kandolf; Martin Bornhäuser
Acute heart failure after allogeneic blood stem cell transplantation due to massive myocardial infiltration by cytotoxic T cells of donor origin.
Bone marrow transplantation 2001;27(1):107-9.
2001: Ulf Renner; Christian Thiede; Martin Bornhäuser; Gerhard Ehninger; HM Thiede
Determination of mycophenolic acid and mycophenolate mofetil by high-performance liquid chromatography using postcolumn derivatization.
Analytical chemistry 2001;73(1):41-6.
2000: Rainer Ordemann; Ralph Naumann; G Geissler; Frank Kroschinsky; Martin Bornhäuser; Rainer Schwerdtfeger; Gerhard Ehninger
Foscarnet--an alternative for cytomegalovirus prophylaxis after allogeneic stem cell transplantation?
Annals of hematology 2000;79(8):432-6.
2000: Martin Bornhäuser; Catrin Theuser; Silke Soucek; Kristina Hölig; T Klingebiel; W Blau; Axel A Fauser; Volker Runde; W Schwinger; Claudia Rutt; Gerhard Ehninger
Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
Haematologica 2000;85(8):839-47.
2000: Martin Bornhäuser; Christian Thiede; Ulrich Schuler; Uwe Platzbecker; Jens Freiberg-Richter; Anett Helwig; R Plettig; Christoph Röllig; Ralph Naumann; Frank Kroschinsky; Andreas Neubauer; Gerhard Ehninger
Dose-reduced conditioning for allogeneic blood stem cell transplantation: durable engraftment without antithymocyte globulin.
Bone marrow transplantation 2000;26(2):119-25.
2000: Brigitte Mohr; Martin Bornhäuser; Christian Thiede; Ulrike Schäkel; Markus Schaich; Thomas Illmer; Ulrich Pascheberg; Gerhard Ehninger
Comparison of spectral karyotyping and conventional cytogenetics in 39 patients with acute myeloid leukemia and myelodysplastic syndrome.
Leukemia 2000;14(6):1031-8.
2000: Olle Ringdén; Mats Remberger; Volker Runde; Martin Bornhäuser; Igor Wolfgang Blau; Nadezda Basara; Kristina Hölig; Dietrich W Beelen; Hans Hägglund; Oliver Basu; Gerhard Ehninger; Axel A Fauser
Faster engraftment of neutrophils and platelets with peripheral blood stem cells from unrelated donors: a comparison with marrow transplantation.
Bone marrow transplantation 2000;25 Suppl 2():S6-8.
2000: Christian Thiede; Gabriele Prange-Krex; Jens Freiberg-Richter; Martin Bornhäuser; Gerhard Ehninger
Buccal swabs but not mouthwash samples can be used to obtain pretransplant DNA fingerprints from recipients of allogeneic bone marrow transplants.
Bone marrow transplantation 2000;25(5):575-7.
2000: T Köhler; R Plettig; W Wetzstein; Marc Schmitz; M Ritter; B Mohr; U Schaekel; Gerhard Ehninger; Martin Bornhäuser
Cytokine-driven differentiation of blasts from patients with acute myelogenous and lymphoblastic leukemia into dendritic cells.
Stem cells (Dayton, Ohio) 2000;18(2):139-47.
1999: C Brendel; Brigitte Mohr; C Schimmelpfennig; J Müller; Martin Bornhäuser; M Schmidt; Markus Ritter; Gerhard Ehninger; Andreas Neubauer
Detection of cytogenetic aberrations both in CD90 (Thy-1)-positive and (Thy-1)-negative stem cell (CD34) subfractions of patients with acute and chronic myeloid leukemias.
Leukemia 1999;13(11):1770-5.
1999: Martin Bornhäuser; Christian Thiede; C Brendel; G Geissler; U Oelschlägel; Andreas Neubauer; Gerhard Ehninger
Stable engraftment after megadose blood stem cell transplantation across the HLA barrier: the case for natural killer cells as graft-facilitating cells.
Transplantation 1999;68(1):87-8.
1999: Olle Ringdén; Mats Remberger; Volker Runde; Martin Bornhäuser; Igor Wolfgang Blau; Nadezda Basara; Kristina Hölig; Dietrich W Beelen; Hans Hägglund; Oliver Basu; Gerhard Ehninger; Axel A Fauser
Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantation.
Blood 1999;94(2):455-64.
1999: Christian Thiede; M Florek; Martin Bornhäuser; Markus Ritter; Brigitte Mohr; C Brendel; Gerhard Ehninger; Andreas Neubauer
Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection.
Bone marrow transplantation 1999;23(10):1055-60.
1999: R Nowak; U Oelschlägel; Ursula Range; S Bergmann; Martin Bornhäuser; C Hölig; Ulrich Schuler; U Krebs; H Günther; Frank Kroschinsky; Gerhard Ehninger
Flow cytometric DNA quantification in immunophenotyped cells as a sensitive method for determination of aneuploid multiple myeloma cells in peripheral blood stem cell harvests and bone marrow after therapy.
Bone marrow transplantation 1999;23(9):895-900.
1999: Martin Bornhäuser; Ulrich Schuler; G Pörksen; Ralph Naumann; G Geissler; Christian Thiede; Rainer Schwerdtfeger; Gerhard Ehninger; HM Thiede
Mycophenolate mofetil and cyclosporine as graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation.
Transplantation 1999;67(4):499-504.
1999: T Köhler; R Plettig; W Wetzstein; B Schaffer; Rainer Ordemann; H O Nagels; Gerhard Ehninger; Martin Bornhäuser
Defining optimum conditions for the ex vivo expansion of human umbilical cord blood cells. Influences of progenitor enrichment, interference with feeder layers, early-acting cytokines and agitation of culture vessels.
Stem cells (Dayton, Ohio) 1999;17(1):19-24.
1998: Martin Bornhäuser; Brigitte Mohr; U Ehrenlechner; Andreas Neubauer; Gerhard Ehninger
Fluorescence in situ hybridization for the BCR/ABL rearrangement is dependent on the percentage of nonlymphocytic cells in peripheral blood stem cell harvests.
Journal of hematotherapy 1998;7(5):425-30.
1998: Rainer Ordemann; Kristina Hölig; K Wagner; U Rautenberg; Martin Bornhäuser; Frank Kroschinsky; J Schäfer; Ulrich Schuler; Gerhard Ehninger
Acceptance and feasibility of peripheral stem cell mobilisation compared to bone marrow collection from healthy unrelated donors.
Bone marrow transplantation 1998;21 Suppl 3():S25-8.
1998: Martin Bornhäuser; M Schmidt; U Ehninger; J von Keller; Ulrich Schuler; Gerhard Ehninger
Computer-based quality control in high-dose chemotherapy and bone marrow transplantation.
Bone marrow transplantation 1998;21(5):505-9.
1997: Martin Bornhäuser; Rainer Ordemann; U Paaz; Ulrich Schuler; J Kömpf; Kristina Hölig; Gerhard Ehninger
Rapid engraftment after allogeneic ABO-incompatible peripheral blood progenitor cell transplantation complicated by severe hemolysis.
Bone marrow transplantation 1997;19(3):295-7.